Pediatric Craniosynostosis Treatment Market Research Report - Forecast to 2027

Pediatric Craniosynostosis Treatment Market Research Information: By Type (Single-Suture, Double-Suture, Complex Multisuture), by Diagnosis (Genetic Testing, Imaging Studies), Treatment (Surgery, Baby Helmet Therapy), End-User - Global Forecast Till 2027

ID: MRFR/Pharma/4271-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Craniosynostosis is a common cranial malformation resulting from the premature fusion of cranial sutures and changing of the skull’s growth pattern. Generally, craniosynostosis is classified into two broad categories, namely, syndromic and nonsyndromic. Syndromic craniosynostosis accounts for approximately 25% of reported cases, and results from more than 180 identified monogenic syndromes.


According to the study published in the Journal of Cranio-Maxillofacial Surgery in 2016, it was found that the prevalence of craniosynostosis is nearly 3.1 to 6.4 in 10.000 live births, which is reportedly rising. On considering the historical data, it is found that the prevalence of craniosynostosis, specially, sagittal and metopic suture synostosis, has risen significantly from 1997 until 2013. It is also reported that Sagittal synostosis was the most common type among all i.e. 44%. The Sagittal synostosis occurs predominantly in males.


Notably, rising technological advancements is the key factor driving the pediatric craniosynostosis treatment market. It has been observed that most of population has been giving preference to minimally invasive surgery for the therapeutic purpose. The major appealing aspects about opting minimally invasive procedure are short hospital stay, less pain, small or no incision, quick recovery time, and reduction in blood loss.


Various other push factors such as increasing awareness among people, escalating prevalence of craniosynostosis, increasing government assistance, amendments in regulatory framework, and rising funding and reimbursement are continuously contributing to the growth of the global pediatric craniosynostosis treatment market.


Despite these drivers, there are some issues associated with the pediatric craniosynostosis treatment market. Lack of skilled physicians and endoscopists, challenges in research and development, risk of infections caused by endoscopes, high cost of treatment, and poor healthcare system in low and middle-income countries may hamper the market growth.


It is estimated that the pediatric craniosynostosis treatment market is expected to grow at a CAGR 6.0% during the forecast period of 2017–2023.


Research Methodology:


 Pediatric Craniosynostosis Treatment


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The global pediatric craniosynostosis treatment market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, the market is segmented into single-suture synostosis, double-suture synostosis, and complex multisuture synostosis. The single-suture synostosis is further segmented into sagittal suture synostosis, coronal suture synostosis, metopic suture synostosis, and lambdoidal suture synostosis. The double-suture synostosis is further segmented into bicoronal, bilambdoid and sagittal plus metopic.


On the basis of diagnosis, the market is classified into physical examination, genetic testing, and imaging studies.


On the basis of treatment, the market is classified as stereotactic image guided endoscopic craniosynostosis repair, standard craniosynostosis surgery, baby helmet therapy, and others. The stereotactic image guided endoscopic craniosynostosis repair is further segmented into real-time stereotactic-endoscopic craniectomy and endoscopic strip sagittal craniectomy. The standard craniosynostosis surgery is further segmented into strip sagittal craniectomy, Frontal-Orbital Advancement (FOA), and Frontal-Occipital Reversal (FOR).


On the basis of end-user, the market is segmented into hospital, clinics, diagnostic centers, and others.


Regional Analysis


The Americas dominate the pediatric craniosynostosis treatment market owing to the rising awareness about disease and high healthcare expenditure. The total health expenditure in the United States was reported to be USD 3.2 trillion, suggested by the Centers for Disease Control and Prevention (CDC). Whereas, hospital care accounted for a share of 32.3%, in 2015.


Europe holds the second position in the pediatric craniosynostosis treatment market. It is expected that the support provided by the government and private associations for research & development and amendments in reimbursement policies in healthcare are likely to promote the market of the European region. The rising prevalence of craniosynostosis in the European region is also expected to boost the market growth. The prevalence of craniosynostosis is found to be around 7.2 per 10.000 live born children in the Netherlands, suggested by the Journal of Cranio-Maxillofacial Surgery in 2016.


Asia Pacific is the fastest growing region in the pediatric craniosynostosis treatment market owing to the developing healthcare technology. Healthcare expenditure is also found to be escalating in various Asian countries. As per the statistics suggested by the Australian Institute of Health and Welfare, the total health expenditure was USD 170.4 billion during the years 2015 to 2016 i.e. 3.6% higher than the expenditure of 2014 to 2015.


The Middle East & Africa holds the lowest market share in the pediatric craniosynostosis treatment market due to lack of technical knowledge and poor medical facilities.


Key Players


Some of the key players in the global pediatric craniosynostosis treatment market are Arthrex Inc., B. Braun Melsungen AG, Cogentix Medical, CONMED Corporation, Cook Medical, Frontier Healthcare, Fujifilm Holdings Corporation, Hoya Corporation, Johnson & Johnson Services, Inc., KARL STORZ GmbH & Co. KG, Medtronic Plc, Minntech Corporation, Olympus Corporation, Pentax Medical, Richard Wolf GmbH, Siemens Healthcare, Smith & Nephew Plc, STERIS Corporation, Stryker Corporation, US Endoscopy Group, and others.



Frequently Asked Questions (FAQ) :


Craniosynostosis is a common cranial malformation resulting from the premature fusion of cranial sutures and changing of the skull’s growth pattern.

The Pediatric Craniosynostosis Market is expected to exhibit a strong 6% CAGR over the forecast period from 2017 to 2023.

Increasing availability of minimally invasive surgeries for fixing the problem is the major driver for the Pediatric Craniosynostosis Market.

The Americas dominate the global Pediatric Craniosynostosis Market due to the widespread awareness among parents.

Leading players in the Pediatric Craniosynostosis Market include Arthrex, Cogentix Medical, and Fujifilm Holding, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Pediatric Craniosynostosis Treatment Market, by Type

6.1 Introduction

6.2 Single-Suture Synostosis

6.2.1 Market Estimates & Forecast, 2020–2027

6.3 Double-Suture Synostosis

6.3.1 Market Estimates & Forecast, 2020–2027

6.4 Complex Multisuture Synostosis

6.4.1 Market Estimates & Forecast, 2020–2027

Chapter 7. Global Pediatric Craniosynostosis Treatment Market, by Diagnosis

7.1 Introduction

7.2 Physical Examination

7.2.1 Market Estimates & Forecast, 2020–2027

7.3 Genetic Testing

7.3.1 Market Estimates & Forecast, 2020–2027

7.4 Imaging Studies

7.4.1 Market Estimates & Forecast, 2020–2027

Chapter 8. Global Pediatric Craniosynostosis Treatment Market, by Treatment

8.1 Introduction

8.2 Stereotactic Image Guided Endoscopic Craniosynostosis Repair

8.2.1 Market Estimates & Forecast, 2020–2027

8.3 Standard Craniosynostosis Surgery

8.3.1 Market Estimates & Forecast, 2020–2027

8.4 Baby Helmet Therapy

8.4.1 Market Estimates & Forecast, 2020–2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020–2027

Chapter 9. Global Pediatric Craniosynostosis Treatment Market, by End-User

9.1 Introduction

9.2 Hospital

9.2.1 Market Estimates & Forecast, 2020–2027

9.3 Clinics

9.3.2 Market Estimates & Forecast, 2020–2027

9.4 Diagnostic Centers

9.4.1 Market Estimates & Forecast, 2020–2027

9.5 Others

9.5.2 Market Estimates & Forecast, 2020–2027

Chapter 10. Global Pediatric Craniosynostosis Treatment Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Arthrex Inc.

11.1.1 Company Overview

11.1.2 Types Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 B. Braun Melsungen AG

11.2.1 Company Overview

11.2.2 Types Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Cogentix Medical

11.3.1 Company Overview

11.3.2 Types Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Medtronic

11.4.1 Company Overview

11.4.2 Types/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 CONMED Corporation

11.5.1 Company Overview

11.5.2 Types Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Cook Medical

11.6.1 Company Overview

11.6.2 Types Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 JOHNSON & JOHNSON SERVICES, INC.

11.7.1 Overview

11.7.2 Types Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pediatric Craniosynostosis Treatment Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Pediatric Craniosynostosis Treatment Industry Synopsis, 2020–2027

Table 2 Pediatric Craniosynostosis Treatment Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Pediatric Craniosynostosis Treatment Market, by Region, 2020–2027, (USD Million)

Table 4 Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 5 Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 6 Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 7 Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 8 North America Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 9 North America Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 11 North America Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 12 US Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 13 US Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 US Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 15 US Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 17 Canada Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 18 Canada Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 19 Canada Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 20 South America Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 21 South America Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 South America Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 23 South America Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 25 Europe Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Europe Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 27 Europe Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 29 Western Europe Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 30 Western Europe Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 31 Western Europe Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 33 Eastern Europe Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 34 Eastern Europe Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 35 Eastern Europe Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia Pacific Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 37 Asia Pacific Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 38 Asia Pacific Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 39 Asia Pacific Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

Table 40 Middle East & Africa Pediatric Craniosynostosis Treatment Market, by Type, 2020–2027, (USD Million)

Table 41 Middle East & Africa Pediatric Craniosynostosis Treatment Market, by Diagnosis, 2020–2027, (USD Million)

Table 42 Middle East & Africa Pediatric Craniosynostosis Treatment Market, by Treatment, 2020–2027, (USD Million)

Table 43 Middle East & Africa Pediatric Craniosynostosis Treatment Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Pediatric Craniosynostosis Treatment Market

Figure 3 Segmentation Market Dynamics for Pediatric Craniosynostosis Treatment Market

Figure 4 Global Pediatric Craniosynostosis Treatment Market Share, by Type 2020

Figure 5 Global Pediatric Craniosynostosis Treatment Market Share, by Diagnosis 2020

Figure 6 Global Pediatric Craniosynostosis Treatment Market Share, by Treatment 2020

Figure 7 Global Pediatric Craniosynostosis Treatment Market Share, by End-User, 2020

Figure 8 Global Pediatric Craniosynostosis Treatment Market Share, by Region, 2020

Figure 9 North America Pediatric Craniosynostosis Treatment Market Share, by Country, 2020

Figure 10 Europe Pediatric Craniosynostosis Treatment Market Share, by Country, 2020

Figure 11 Asia Pacific Pediatric Craniosynostosis Treatment Market Share, by Country, 2020

Figure 12 Middle East & Africa Pediatric Craniosynostosis Treatment Market Share, by Country, 2020

Figure 13 Global Pediatric Craniosynostosis Treatment Market: Company Share Analysis, 2020 (%)

Figure 14 Arthrex Inc.: Key Financials

Figure 15 Arthrex Inc. Segmental Revenue

Figure 16 Arthrex Inc.: Geographical Revenue

Figure 17 B. Braun Melsungen AG: Key Financials

Figure 18 B. Braun Melsungen AG: Segmental Revenue

Figure 19 B. Braun Melsungen AG: Geographical Revenue

Figure 20 Cogentix Medical: Key Financials

Figure 21 Cogentix Medical: Segmental Revenue

Figure 22 Cogentix Medical: Geographical Revenue

Figure 23 Medtronic: Key Financials

Figure 24 Medtronic: Segmental Revenue

Figure 25 Medtronic: Geographical Revenue

Figure 26 CONMED Corporation: Key Financials

Figure 27 CONMED Corporation: Segmental Revenue

Figure 28 CONMED Corporation Geographical Revenue

Figure 29 Cook Medical: Key Financials

Figure 30 Cook Medical: Segmental Revenue

Figure 31 Cook Medical: Geographical Revenue

Figure 32 JOHNSON & JOHNSON SERVICES, INC.: Key Financials

Figure 33 JOHNSON & JOHNSON SERVICES, INC.: Segmental Revenue

Figure 34 JOHNSON & JOHNSON SERVICES, INC.: Geographical Revenue